Shuangteng Jingu Pian (双藤筋骨片)双藤筋骨片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

扶芳藤是一种在国家药监局注册认定的药品。该药品含有忍冬藤、扶芳藤、淫羊藿-21612125等成分。

该药品关联的活性成分包括:忍冬藤Rendong Teng、扶芳藤Fufang Teng、淫羊藿Yinyang Huo、独活Du Huo、穿山龙Chuanshan Long。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:陕西摩美得制药有限公司Chinese legal name: 陕西摩美得制药有限公司。

您可以探索含有相同成分的其他药品:忍冬藤-d4d533ed成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 双藤筋骨片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 忍冬藤Rendong Teng, 扶芳藤Fufang Teng, 淫羊藿Yinyang Huo, 独活Du Huo, 穿山龙Chuanshan Long.

Manufacturers recorded for this product: 陕西摩美得制药有限公司Chinese legal name: 陕西摩美得制药有限公司.

Explore other medicines containing the same ingredient: 忍冬藤 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 双藤筋骨片Recorded Chinese name: 双藤筋骨片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 0.25g*45片0.25 g × 45 tablets

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 陕西摩美得制药有限公司Chinese legal name: 陕西摩美得制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20040081

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20040081

Manufacturer

Chinese legal name: 陕西摩美得制药有限公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

0.25 g × 45 tablets

中文说明书原文Original Chinese source label

批准文号

国药准字Z20040081

生产企业

陕西摩美得制药有限公司(国产)

功能主治

祛风除湿,散寒止痛,活血通络。用于骨性关节炎寒湿阻络证所致的关节疼痛、沉重、活动受限、劳累及受寒后加重等。

用法用量

口服,一次5-7片,一日3次,4周为一疗程。

不良反应

偶可出现胃部不适,灼热泛酸。

禁忌

孕妇禁用。

注意事项

有胃病者宜饭后服用。

贮藏

密封。

规格

0.25g*45片

证据Evidence

  • 批准文号: 国药准字Z20040081
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.